Traws Pharma, Inc. Public Float
Traws Pharma, Inc. (TRAW) had Public Float of $9.80 million as of 2025-06-30, per its 10-K/A filed 2026-04-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-30
- 2025-06-30: Entity Public Float $9.80M.
- 2024-06-30: Entity Public Float $9.60M.
- 2023-06-30: Entity Public Float $24.60M.
- 2022-06-30: Entity Public Float $27.50M.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $9.80M 10-K/A · filed 2026-04-30 | |
| 2024-06-30 | $9.60M 10-K/A · filed 2025-04-30 | |
| 2023-06-30 | $24.60M 10-K/A · filed 2024-04-29 | |
| 2022-06-30 | $27.50M 10-K/A · filed 2023-05-01 | |
| 2021-06-30 | $109.00 10-K/A · filed 2022-04-29 | $109.00M 10-K · filed 2022-03-21 |
| 2020-06-30 | $98.40M 10-K · filed 2021-03-18 | |
| 2019-06-28 | $16.30M 10-K · filed 2020-03-27 | |
| 2018-06-30 | $32.70M 10-K · filed 2019-04-01 | |
| 2017-06-30 | $17.80M 10-K · filed 2018-03-16 | |
| 2016-06-30 | $10.60M 10-K · filed 2017-03-29 | |
| 2015-06-30 | $30.10M 10-K · filed 2016-03-28 | |
| 2014-06-30 | $68.70M 10-K · filed 2015-03-30 | |
| 2013-06-28 | $107.30M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |